Flonoltinib Maleate

Flonoltinib maleate · Chengdu Zenitar Biomedical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flonoltinib Maleate, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis [Phase 3]